Capcom’s Monster Hunter Wilds Tops 10 Million Units Sold!
Capcom Co., Ltd. (TOKYO:9697) today announced that worldwide sales of Monster Hunter Wilds, released on February 28, 2025, surpassed 10 million units.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250331348660/en/
Monster Hunter Wilds Title Logo
Monster Hunter Wilds is the latest entry in the Monster Hunter series and is set in a dynamically changing world that is in one moment a severe wilderness, swarming with packs of attacking monsters, and in the next transforms into a rich natural environment teeming with life. The title features grand, beautiful visual depictions made possible by the RE ENGINE, Capcom’s proprietary game development engine, and crossplay, allowing players to enjoy the game together regardless of their game platform.
The title provides an environment where a wider range of players can enjoy the game together with the introduction of crossplay, a first for the series, and a simultaneous release on Playstation®5 system, Xbox Series X|S, and PC. Additionally, the introduction of the new Focus Mode mechanic and the implementation of seamless movement between settlements and ecosystems have provided an even more immersive gaming experience, while the fusion of numerous new elements with Monster Hunter’s appeal has generated significant excitement, all of which led to the company first-month sales record of over 10 million units sold. Additionally, the first free Title Update is scheduled for April 4th, which will add a fan-favorite monster as well as the Grand Hub, a new in-game settlement where players can gather and communicate with each other. Going forward, Capcom plans to continue to release updates that will delight players, such as the second Title Update which is scheduled for release in the summer.
Capcom remains firmly committed to satisfying the expectations of all users by leveraging its industry leading game development capabilities in order to create highly entertaining gameplay experiences.
About the Monster Hunter series:
The Monster Hunter series consists of hunting action games that pit players against giant monsters in beautiful natural environments. Beginning with the first title in 2004, the series established a new genre in which players cooperate to hunt ferocious monsters with their friends, growing into a global phenomenon with cumulative sales of the series exceeding 108 million units (as of December 31, 2024).
ABOUT CAPCOM
Capcom is a leading worldwide developer, publisher and distributor of interactive entertainment for game consoles, PCs, handheld and wireless devices. Founded in 1983, the company has created hundreds of games, including groundbreaking franchises Resident Evil™, Monster Hunter™, Street Fighter™, Mega Man™, Devil May Cry™ and Ace Attorney™. Capcom maintains operations in the U.S., U.K., Germany, France, Hong Kong, Taiwan, Singapore and Tokyo, with corporate headquarters located in Osaka, Japan. More information about Capcom can be found at https://www.capcom.co.jp/ir/english/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250331348660/en/
Contacts
Capcom Public Relations & Investor Relations Section
+81-6-6920-3623
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Frontgrade Gaisler Launches New GRAIN Line and Wins SNSA Contract to Commercialize First Energy-Efficient Neuromorphic AI for Space Applications2.4.2025 09:00:00 EEST | Press release
The Swedish National Space Agency (SNSA) has awarded Frontgrade Gaisler, a leading provider of radiation-hardened microprocessors for space missions, a contract to commercialize the first neuromorphic System on Chip (SoC) device for space applications. Already in development at Frontgrade Gaisler, the device is part of the company’s new GRAIN (Gaisler Research Artificial Intelligence NOEL-V) product line. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250401194593/en/ Frontgrade Gaisler, a leading provider of radiation-hardened microprocessors for space missions, has launched its new Gaisler Research Artificial Intelligence NOEL-V (GRAIN) product line. The first GRAIN device to premiere – the Gr801 SoC – integrates Akida™ neuromorphic technology from BrainChip, the world’s first commercial producer of ultra-low power, fully digital, event-based, neuromorphic AI. The first GRAIN device that Frontgrade Gaisler will premiere –
Allshares Acquires Bolago to Strengthen Global Leadership and Expand Equity Management Offering2.4.2025 08:00:00 EEST | Press release
Allshares, a leading provider of equity and incentive management solutions, today announced the acquisition of Bolago, a company offering digital solutions for share programs, option schemes, and investments. The acquisition reinforces Allshares’ position as a leading global platform for end-to-end equity plan management and expands its capabilities in supporting growth-stage businesses and entrepreneurs. The deal follows Allshares’ recently announced accelerated growth strategy and builds on its global momentum. By integrating Bolago’s advanced technology for scenario planning and equity modeling, Allshares will broaden its product offering and further empower companies to manage incentive programs at scale. Hannes Rosén, CEO of Bolago, shared his excitement about the partnership: “Over the years, we’ve built a strong and diverse customer base and a talented team. Joining Allshares is a unique opportunity to elevate our service delivery with tech-forward compensation and equity softwa
Desentum Reports Strong Safety and Immunological Data From Phase 1 Clinical Study With Investigational Birch Pollen Allergy Vaccine DM-101PX2.4.2025 07:20:00 EEST | Press release
Desentum Oy, a clinical-stage biopharmaceutical company developing novel immunotherapies for treating allergies, announces positive clinical data with birch pollen allergy vaccine DM-101PX. The short-course treatment was found to be safe and well tolerated in birch pollen allergic patients and to induce a very strong and sustained allergen-specific IgG4 response. DM-101PX-induced immunoglobulins were found to efficiently block IgE-mediated basophil activation endorsing the product’s potential to induce a protective immune response. The randomised, double-blind, placebo-controlled study evaluated three dose escalation regimens, each consisting of ten subcutaneous injections over 10 weeks with DM-101PX or placebo in a total of thirty birch pollen allergic adults. No serious or severe adverse events occurred, and most adverse events were local injection-site reactions that are typically seen in subcutaneous allergen immunotherapy. Nearly all patients reached their targeted maximum dose. T
GE HealthCare and FPT Expand Strategic Partnership to Drive AI-Powered Healthcare Innovation2.4.2025 07:06:00 EEST | Press release
Global IT firm FPT and GE HealthCare announced a Strategic Cooperation Agreement, expanding their commercial alliance to advance product strategy and development, and establish an FPT Competency Center in Vietnam. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250401306987/en/ This deepening collaboration reflects a strategic shift from project-based engagement to a long-term alliance aimed at accelerating the adoption of AI-driven solutions, enhancing operational efficiency, and improving patient care. As part of the commercial alliance, FPT will become a channel partner for GE HealthCare, jointly promoting and delivering GE HealthCare’s digital solutions in Vietnam and throughout its country network. FPT also plans on collaborating with GE HealthCare’s Science & Technology Office and affiliates to co-develop new and further develop GE HealthCare’s existing and new digital healthcare products. A key highlight of the partner
Former Mitsubishi IP Leader to Head Sisvel Japan2.4.2025 07:00:00 EEST | Press release
Yoshinori Shimizu has become managing director of the Japanese office of Sisvel, Europe’s biggest and longest-established patent pool operator. The appointment coincides with the retirement of Tetsuro Fuse, who will continue to work with Sisvel in an advisory capacity. Mr Shimizu is widely acknowledged as one of Japan’s leading IP professionals and most recently served as Deputy General Manager of the Corporate Export Control Division at Mitsubishi Electric Corporation, where he worked for 29 years. During his time at Mitsubishi, Mr Shimizu was instrumental in shaping the company’s global IP strategy, negotiating patent licensing agreements and resolving disputes. He has also played a key role in several patent pool initiatives, including those operated by Sisvel. As managing director of Sisvel Japan, Mr Shimizu will work closely with Sisvel’s global leadership team to drive the continued growth of the firm’s licensing programmes in Japan and across Asia. “Having worked with Sisvel as
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom